Table 3.
TBV-to-eTIV (%) | HV-to-eTIV (%) | WMHV-to-eTIV (%) | ||||
---|---|---|---|---|---|---|
Age- and sex-adjusted | Multivariable-adjusted | Age- and sex-adjusted | Multivariable-adjusted | Age- and sex-adjusted | Multivariable-adjusted | |
Physical frailty status | ||||||
Robust | 59.1 (58.8–59.4) | 59.0 (58.6–59.5) | 0.48 (0.47–0.49) | 0.48 (0.47–0.49) | 0.29 (0.26–0.31) | 0.29 (0.25–0.33) |
Prefrail | 58.5 (58.1–58.9)* | 58.5 (58.0–59.0)* | 0.47 (0.46–0.48) | 0.47 (0.47–0.48) | 0.35 (0.31–0.38)* | 0.35 (0.31–0.40)* |
Components of the physical frailty | ||||||
Weight loss | ||||||
No | 58.9 (58.7–59.2) | 58.9 (58.5–59.3) | 0.48 (0.47–0.48) | 0.48 (0.47–0.49) | 0.30 (0.28–0.33) | 0.31 (0.27–0.35) |
Yes | 58.3 (57.6–59.0) | 58.4 (57.6–59.2) | 0.47 (0.46–0.48) | 0.47 (0.46–0.49) | 0.34 (0.27–0.41) | 0.36 (0.28–0.43) |
Slowness | ||||||
No | 59.0 (58.8–59.2) | 59.0 (58.6–59.4) | 0.48 (0.47–0.48) | 0.48 (0.47–0.49) | 0.29 (0.27–0.31) | 0.29 (0.26–0.33) |
Yes | 57.4 (56.6–58.2)* | 57.4 (56.6–58.3)* | 0.47 (0.46–0.48)* | 0.46 (0.45–0.48)* | 0.49 (0.42–0.57)* | 0.49 (0.41–0.58)* |
Weakness | ||||||
No | 58.9 (58.7–59.1) | 58.8 (58.4–59.2) | 0.48 (0.47–0.48) | 0.48 (0.47–0.49) | 0.30 (0.28–0.32) | 0.31 (0.27–0.35) |
Yes | 58.6 (57.8–59.4) | 58.6 (57.7–59.4) | 0.48 (0.46–0.49) | 0.46 (0.45–0.49) | 0.38 (0.31–0.46)* | 0.40 (0.31–0.48)* |
Exhaustion | ||||||
No | 58.9 (58.6–59.1) | 58.8 (58.4–59.2) | 0.48 (0.47–0.48) | 0.48 (0.47–0.49) | 0.31 (0.28–0.33) | 0.31 (0.28–0.35) |
Yes | 59.5 (57.9–61.0) | 58.6 (58.0–61.2) | 0.49 (0.46–0.52) | 0.49 (0.46–0.52) | 0.43 (0.28–0.58) | 0.42 (0.27–0.57) |
Low physical activity | ||||||
No | 58.9 (58.7–59.2) | 58.8 (58.4–59.2) | 0.48 (0.47–0.47) | 0.48 (0.47–0.49) | 0.31 (0.28–0.33) | 0.31 (0.28–0.35) |
Yes | 58.7 (58.1–59.3) | 58.6 (57.9–59.3) | 0.47 (0.46–0.48) | 0.47 (0.46–0.49) | 0.32 (0.26–0.38) | 0.32 (0.26–0.39) |
Values are shown as a mean value (95% confidence interval).
In the multivariable-adjusted model, the values were adjusted for age, sex, educational level, hypertension, diabetes mellitus, LDL and HDL cholesterol levels, ApoE E4 carrier status, MMSE score, and GDS score.
*Benjamini–Hochberg false discovery rate-adjusted p value, q < 0.05.